Researchers have developed an AI tool that creates synthetic yet medically accurate models of fibrotic heart tissue (heart scarring), aiding treatment planning for atrial fibrillation (AF) patients.

The global atrial fibrillation market is projected to witness robust growth over the next decade. In 2023, the market generated a substantial revenue of US$ 3,505.7 million and is estimated to achieve ...

Researchers from Queen Mary University of London have developed an AI tool that creates synthetic yet medically accurate models of fibrotic heart tissue (heart scarring), aiding treatment planning for ...

A group of 29 international medical experts is calling for a major change in how we screen for heart disease. In a recent ...

An NIH-funded clinical trial is exploring the potential role of wearables in managing atrial fibrillation (AFib ... effectiveness of a more personalized treatment approach.

Portable ECG devices—small portable ECG monitors or smartwatches that detect atrial fibrillation in under ... start appropriate treatment, and save lives," concludes Niiranen.

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, ...

1.87% treatment). Atrial fibrillation burden decreased progressively ... Cardiac Rhythm Management Division, Sylmar, CA). Devices were programmed to DDDR pacing with a base rate of 60 bpm ...